- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Siemens’ oncology group wins award
The Siemens Oncology Care Systems Group won California Governor Gray Davis’ 1999 Quality Award for Overall Excellence for its work in oncology. This award recognizes overall excellence in all business areas, including management, marketplace,
The Siemens Oncology Care Systems Group won California Governor Gray Davis 1999 Quality Award for Overall Excellence for its work in oncology. This award recognizes overall excellence in all business areas, including management, marketplace, workplace, and community. The Oncology Care Systems Group, based in Concord, CA, was founded in 1974. It manufactures and develops radiation therapy products for the worldwide oncology market. The group has brought intensity-modulated radiation therapy (IMRT) to smaller clinics across the U.S. IMRT is usually found in large hospitals. This treatment delivers complex doses of radiation to tumors while minimizing the effect on surrounding tissue.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
